MWAI · MedWellAI, Inc.
$0.20
-0.12 (-37.50%)
At close · Oct 19
Return incl. dividend (before tax)
Going-concern doubt
— flagged Oct 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Historically, the Company has reported recurring net losses from operations and used net cash in operating activities. As of June 30, 2026, the Company’s current liabilities exceeded its current assets by $7,847,263 and the Company had an accumulated deficit of $90,263,345. These conditions raise substantial doubt about the Company’s ability to continue as a going concern.”View the 10-K filed Oct 13, 2026
Market Cap
$1.31M
Shares
6.54M
Volume · Oct 19
18.3K
Avg daily vol (3M)
2950
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.20
Open$0.24
Day$0.20–0.24
52W close$0.20–0.77
Avg vol 30d3K
Short int3K · 0.0% float · 1.6d
Short vol54%
DataJan 2020–Oct 2026
Filing10-K · Oct 13
Up next
filed Oct 13, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$527,857
Trailing 12 months
Net income (TTM)
−$1.59M
Trailing 12 months
Revenue growth YoY
-533.9%
Year over year
Operating margin
-234.2%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-67.5%
Year over year · fewer shares
Price change (1Y)
-52.9%
Trailing year
Short interest
0.0%
Latest settlement · 1.6 days to cover
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 18.4 · elevated
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−57%
below
Price vs 50-day avg
−35%
below
RSI (14)
36
neutral
MACD trend
Negative
52-week position
0%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−43%
trailing
6-month return
−73%
trailing
YTD return
−60%
this year
Relative strength
−81%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Distributing
2 of 16 funds reported for Sep 30 · net -11.4K sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.04% of float · ▼ -40.0% MoM · 1.6 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr high
16 holders — near 3-yr high, broad support
Squeeze score
18
low risk · 0–100
Fundamentals
Revenue growth
−11%
Y/Y
Gross margin
-461%
contracting
EPS growth
+77%
Y/Y
Free cash flow
$-307.0K
Quant / Vol
risk profile
Volatility
203%
annualized · 1-yr
Max drawdown
−74%
past year
ATR
37.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−57%
Bearish
Price vs 50-day avg
−35%
Bearish
RSI (14)
36
Neutral
MACD trend
Negative
Bearish
52-week position
0%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Distributing
2 of 16 funds reported for Sep 30 · net -11.4K sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.04% of float · ▼ -40.0% MoM · 1.6 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr high
16 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $0
Now $0 · 0%
Range high $1
vs 200-day avg -57%
vs 50-day avg -35%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
Versus peers
Capital Markets — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MWAI
this stock
MedWellAI, Inc.
|
$1.31M | -60.0% | -11.2% | — | 0.0% |
|
MS
Morgan Stanley
|
$280.30B | +1.6% | +5.5% | 14.4 | 0.9% |
|
GS
Goldman Sachs Group Inc
|
$255.00B | +0.7% | +8.9% | 13.5 | 2.3% |
|
SCHW
Schwab Charles Corp
|
$154.91B | -9.0% | +22.0% | 16.3 | 1.1% |
|
HOOD
Robinhood Markets, Inc.
|
$86.78B | -13.2% | +51.6% | 42.7 | 4.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
15
- % held
- 13.1%
- Reported
- 2 of 16
- Top holder
- First Pacific Financial
Held
Float
Short & Settlement
Financials
Filings
SEC Filings
Latest
10-K
- Filed
- Oct 13, 2026
- This year
- 6
MedWellAI, Inc. reported a $1,589,465 net loss for the year ended June 30, 2026, while commission revenue fell to $437,857. Current liabilities exceeded current assets by $7,847,263, raising substantial doubt about its ability to continue as a going concern.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MWAI | -37.5% | -42.5% | -73.3% | -37.5% | -60.0% |
| SPY | -1.5% | -0.9% | +7.7% | +0.5% | +12.4% |
| vs SPY | -36.0% | -41.6% | -81.0% | -38.0% | -72.4% |